Patients with presbyopia experienced improvements in near vision after treatment with Brimochol PF in a second phase 3 ...

Strategically focused pipeline optimizes resource allocation to progress two product candidates with strongest clinical proof of concept: 4D-150 ...

Positive interim results in infants and young children with ENPP1 Deficiency showed improvements from baseline in multiple measures of disease, ...

EU looks at India as best option over China, reflecting potential shifts in trade dynamics: Nandita Vijayasimha, Bengaluru Saturday, January 11, 2025, 08:00 Hrs [IST] The European ...

AEON Biopharma (NYSE: AEON) , a clinical-stage biopharmaceutical company focused on developing a botulinum toxin complex under a 351(k) biosimilar p ...

Misses from amyotrophic lateral sclerosis hopefuls Denali Therapeutics and partners AbbVie and Calico Life Sciences mark the ...

Sanofi SNY announced that the phase III IRAKLIA study, which evaluated a fixed-dose subcutaneous (SC) formulation of its ...

US FDA grants priority review status to Johnson & Johnson’s nipocalimab BLA to treat generalized myasthenia gravis: Spring House, Pennsylvania Saturday, January 11, 2025, 12:00 ...

Throughout ‘the year of the election’ – as 2024 was widely known – we were working with politicians and decision-makers to ...

The European pharma sector is on the brink of regulatory and operational updates with new papers from pharmaceutical ...

On Sunday, 12 January, the Regulation on Health Technology Assessment (HTA) will take effect, enhancing access to innovative ...